180 Life Plunges 28.88% as Trading Volume Dives 83.63% to 0.20 Billion Ranking 486th in Market Activity

On August 14, 2025, 180 Life (ATNF) closed at $8.21, reflecting a 28.88% decline from its previous session, with a trading volume of $0.20 billion, representing an 83.63% drop from the prior day. The stock ranked 486th in terms of trading activity across the market.

The pre-market session saw heightened volatility in biotech stocks, with 180 Life Sciences Corp. (ATNF) among the notable decliners. While peers like Sonoma Pharmaceuticals (SNOA) and Biomerica (BMRA) surged on pre-market gains, ATNF’s sharp drop drew attention to its underperformance relative to the sector. The decline followed broader market skepticism toward biotech firms facing regulatory or operational challenges, though no company-specific catalysts were disclosed in the provided materials.

Market participants observed that ATNF’s liquidity constraints, as indicated by its bid-ask spread and reduced trading volume, may have amplified its price movement. The stock’s sharp fall contrasted with positive momentum in other biotech names, highlighting divergent investor sentiment within the sector. Despite the decline, the company’s core operations in life sciences remain unchanged in the context of the provided information.

A backtest of a strategy involving the top 500 stocks by daily trading volume from 2022 to 2025 yielded a total profit of $10,720 as of the latest data. The returns were characterized by steady growth with intermittent fluctuations, underscoring the impact of market dynamics on short-term trading approaches.